Brooks Laboratories informs about clarification

03 May 2023 Evaluate
With reference to email dated 19.04.2023 for Non-submission of Statement of Deviation(s) or Variation(s) for the quarter ended December 31, 2022, Brooks Laboratories has informed that there was no deviation from the proceeds of issues and the funds have been fully utilized and nothing was pending for the quarter ended December 31, 2022. Further, the funds were raised for augment of working capital and we have utilized it immediately and there was no Deviation(s) or Variation(s) in the proceeds of the issues. The details as requested in the mail is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

165.50 3.20 (1.97%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.